blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3502705

EP3502705 - IN VITRO METHOD FOR IDENTIFYING A PREGNANCY RELATED DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.07.2021
Database last updated on 20.07.2024
FormerThe patent has been granted
Status updated on  07.08.2020
FormerGrant of patent is intended
Status updated on  26.03.2020
FormerRequest for examination was made
Status updated on  03.01.2020
FormerThe application has been published
Status updated on  27.05.2019
Most recent event   Tooltip16.06.2023Lapse of the patent in a contracting state
New state(s): NL		published on 19.07.2023  [2023/29]
Applicant(s)For all designated states
Universidad de los Andes
Av. Monseñor Alvaro del Portillo 12.455
Las Condes
Santiago / CL
[2019/26]
Inventor(s)01 / CHAPARRO PADILLA, Alejandra
Universidad de los Andes
Avenida Monseñor Álvaro
del Portillo
12455 Las Condes - Santiago / CL
02 / ILLANES LÓPEZ, Sebastián
Universidad de los Andes
Avenida Monseñor Álvaro
del Portillo
12.455 Las Condes - Santiago / CL
 [2019/26]
Representative(s)Hoffmann Eitle
Hoffmann Eitle S.L.U.
Paseo de la Castellana 140, 3a planta
Edificio LIMA
28046 Madrid / ES
[2019/26]
Application number, filing date19153119.312.09.2016
[2019/26]
Priority number, dateUS201562217270P11.09.2015         Original published format: US 201562217270 P
EP2016016149021.03.2016         Original published format: EP 16161490
[2019/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3502705
Date:26.06.2019
Language:EN
[2019/26]
Type: B1 Patent specification 
No.:EP3502705
Date:09.09.2020
Language:EN
[2020/37]
Search report(s)(Supplementary) European search report - dispatched on:EP14.03.2019
ClassificationIPC:G01N33/68
[2019/26]
CPC:
G01N33/689 (EP,US); A61P3/10 (EP); G01N2333/71 (EP,US);
G01N2800/042 (EP,US); G01N2800/368 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/06]
Former [2019/26]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:IN-VITRO-VERFAHREN ZUR IDENTIFIZIERUNG EINER SCHWANGERSCHAFTSBEDINGTEN ERKRANKUNG[2019/26]
English:IN VITRO METHOD FOR IDENTIFYING A PREGNANCY RELATED DISEASE[2019/26]
French:PROCÉDÉ IN VITRO POUR IDENTIFIER UNE MALADIE ASSOCIÉE À LA GROSSESSE[2019/26]
Examination procedure26.12.2019Amendment by applicant (claims and/or description)
26.12.2019Examination requested  [2020/06]
26.12.2019Date on which the examining division has become responsible
27.03.2020Communication of intention to grant the patent
30.07.2020Fee for grant paid
30.07.2020Fee for publishing/printing paid
30.07.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP16766645.2  / EP3347719
Opposition(s)10.06.2021No opposition filed within time limit [2021/33]
Fees paidRenewal fee
22.01.2019Renewal fee patent year 03
23.09.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.09.2016
AL09.09.2020
AT09.09.2020
CY09.09.2020
CZ09.09.2020
DK09.09.2020
EE09.09.2020
ES09.09.2020
FI09.09.2020
HR09.09.2020
IT09.09.2020
LT09.09.2020
LV09.09.2020
MC09.09.2020
MK09.09.2020
MT09.09.2020
PL09.09.2020
RO09.09.2020
RS09.09.2020
SE09.09.2020
SI09.09.2020
SK09.09.2020
SM09.09.2020
TR09.09.2020
IE12.09.2020
LU12.09.2020
NL23.09.2020
BE30.09.2020
CH30.09.2020
LI30.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
IS09.01.2021
PT11.01.2021
[2023/29]
Former [2022/33]HU12.09.2016
AL09.09.2020
AT09.09.2020
CY09.09.2020
CZ09.09.2020
DK09.09.2020
EE09.09.2020
ES09.09.2020
FI09.09.2020
HR09.09.2020
IT09.09.2020
LT09.09.2020
LV09.09.2020
MC09.09.2020
MK09.09.2020
MT09.09.2020
PL09.09.2020
RO09.09.2020
RS09.09.2020
SE09.09.2020
SI09.09.2020
SK09.09.2020
SM09.09.2020
TR09.09.2020
IE12.09.2020
LU12.09.2020
BE30.09.2020
CH30.09.2020
LI30.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
IS09.01.2021
PT11.01.2021
Former [2022/27]HU12.09.2016
AL09.09.2020
AT09.09.2020
CY09.09.2020
CZ09.09.2020
DK09.09.2020
EE09.09.2020
ES09.09.2020
FI09.09.2020
HR09.09.2020
IT09.09.2020
LT09.09.2020
LV09.09.2020
MC09.09.2020
MT09.09.2020
PL09.09.2020
RO09.09.2020
RS09.09.2020
SE09.09.2020
SI09.09.2020
SK09.09.2020
SM09.09.2020
TR09.09.2020
IE12.09.2020
LU12.09.2020
BE30.09.2020
CH30.09.2020
LI30.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
IS09.01.2021
PT11.01.2021
Former [2021/48]AL09.09.2020
AT09.09.2020
CZ09.09.2020
DK09.09.2020
EE09.09.2020
ES09.09.2020
FI09.09.2020
HR09.09.2020
IT09.09.2020
LT09.09.2020
LV09.09.2020
MC09.09.2020
PL09.09.2020
RO09.09.2020
RS09.09.2020
SE09.09.2020
SI09.09.2020
SK09.09.2020
SM09.09.2020
IE12.09.2020
LU12.09.2020
BE30.09.2020
CH30.09.2020
LI30.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
IS09.01.2021
PT11.01.2021
Former [2021/37]AL09.09.2020
AT09.09.2020
CZ09.09.2020
DK09.09.2020
EE09.09.2020
ES09.09.2020
FI09.09.2020
HR09.09.2020
LT09.09.2020
LV09.09.2020
MC09.09.2020
PL09.09.2020
RO09.09.2020
RS09.09.2020
SE09.09.2020
SI09.09.2020
SK09.09.2020
SM09.09.2020
IE12.09.2020
LU12.09.2020
BE30.09.2020
CH30.09.2020
LI30.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
IS09.01.2021
PT11.01.2021
Former [2021/36]AL09.09.2020
AT09.09.2020
CZ09.09.2020
EE09.09.2020
ES09.09.2020
FI09.09.2020
HR09.09.2020
LT09.09.2020
LV09.09.2020
MC09.09.2020
PL09.09.2020
RO09.09.2020
RS09.09.2020
SE09.09.2020
SI09.09.2020
SK09.09.2020
SM09.09.2020
LU12.09.2020
BE30.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
IS09.01.2021
PT11.01.2021
Former [2021/31]AL09.09.2020
AT09.09.2020
CZ09.09.2020
EE09.09.2020
ES09.09.2020
FI09.09.2020
HR09.09.2020
LT09.09.2020
LV09.09.2020
MC09.09.2020
PL09.09.2020
RO09.09.2020
RS09.09.2020
SE09.09.2020
SK09.09.2020
SM09.09.2020
LU12.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
IS09.01.2021
PT11.01.2021
Former [2021/28]AL09.09.2020
AT09.09.2020
CZ09.09.2020
EE09.09.2020
ES09.09.2020
FI09.09.2020
HR09.09.2020
LT09.09.2020
LV09.09.2020
PL09.09.2020
RO09.09.2020
RS09.09.2020
SE09.09.2020
SK09.09.2020
SM09.09.2020
LU12.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
IS09.01.2021
PT11.01.2021
Former [2021/27]AL09.09.2020
AT09.09.2020
CZ09.09.2020
EE09.09.2020
ES09.09.2020
FI09.09.2020
HR09.09.2020
LT09.09.2020
LV09.09.2020
PL09.09.2020
RO09.09.2020
RS09.09.2020
SE09.09.2020
SM09.09.2020
LU12.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
IS09.01.2021
PT11.01.2021
Former [2021/25]AL09.09.2020
AT09.09.2020
CZ09.09.2020
EE09.09.2020
ES09.09.2020
FI09.09.2020
HR09.09.2020
LT09.09.2020
LV09.09.2020
PL09.09.2020
RO09.09.2020
RS09.09.2020
SE09.09.2020
SM09.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
IS09.01.2021
PT11.01.2021
Former [2021/22]CZ09.09.2020
EE09.09.2020
FI09.09.2020
HR09.09.2020
LT09.09.2020
LV09.09.2020
PL09.09.2020
RO09.09.2020
RS09.09.2020
SE09.09.2020
SM09.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
PT11.01.2021
Former [2021/21]FI09.09.2020
HR09.09.2020
LT09.09.2020
LV09.09.2020
PL09.09.2020
RS09.09.2020
SE09.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
PT11.01.2021
Former [2021/10]FI09.09.2020
HR09.09.2020
LT09.09.2020
LV09.09.2020
PL09.09.2020
RS09.09.2020
SE09.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
Former [2021/09]FI09.09.2020
LT09.09.2020
SE09.09.2020
BG09.12.2020
NO09.12.2020
GR10.12.2020
Former [2021/08]FI09.09.2020
LT09.09.2020
SE09.09.2020
BG09.12.2020
NO09.12.2020
Former [2021/07]FI09.09.2020
LT09.09.2020
NO09.12.2020
Documents cited:Search[A]WO2014142752  (AGENCY SCIENCE TECH & RES [SG], et al) [A] 1-9 * claims 1-16 *;
 [A]WO2006069373  (UNIV YALE [US], et al) [A] 1-9 * claims 1-41 *
 [A]  - OETTINGER-BARAK O ET AL, "Severe pregnancy complication (preeclampsia) is associated with greater periodontal destruction", JOURNAL OF PERIODONTOLOGY,, (20050101), vol. 76, no. 1, ISSN 0022-3492, pages 134 - 137, XP009192226 [A] 1-9 * the whole document *
 [A]  - YU Y ET AL, "Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women", DIABETOLOGIA ; CLINICAL AND EXPERIMENTAL DIABETES AND METABOLISM, SPRINGER, BERLIN, DE, (20081105), vol. 52, no. 1, ISSN 1432-0428, pages 160 - 168, XP019651362 [A] 1-9 * the whole document *
 [A]  - JUNG-EUN HA ET AL, "Oral Health Behaviors, Periodontal Disease, and Pathogens in Preeclampsia: A Case-Control Study in Korea", JOURNAL OF PERIODONTOLOGY., US, (20111201), vol. 82, no. 12, doi:10.1902/jop.2011.110035, ISSN 0022-3492, pages 1685 - 1692, XP009192224 [A] 1-9
 [A]  - CHAPARRO A ET AL, "Increased inflammatory biomarkers in early pregnancy is associated with the development of pre-eclampsia in patients with periodontitis: a case control", JOURNAL OF PERIODONTAL RESEARCH, MUNKSGAARD, (20130601), vol. 48, no. 3, doi:10.1111/JRE.12008, ISSN 0022-3484, pages 302 - 307, XP009192221 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1111/jre.12008
 [A]  - LI JUN ET AL, "Impaired proliferation of pancreatic beta cells, by reduced placental growth factor in pre-eclampsia, as a cause for gestational diabetes mellitus", CELL PROLIFERATION, OXFORD, GB, (20150401), vol. 48, no. 2, doi:10.1111/CPR.12164, ISSN 0960-7722, pages 166 - 174, XP009192223 [A] 1-9 * the whole document *

DOI:   http://dx.doi.org/10.1111/cpr.12164
 [XP]  - CHAPARRO ALEJANDRA ET AL, "Placental biomarkers and angiogenic factors in oral fluids of patients with preeclampsia", PRENATAL DIAGNOSIS MAR 2011,, (20160501), vol. 36, no. 5, doi:10.1002/PD.4811, ISSN 1097-0223, pages 476 - 482, XP009192222 [XP] 1-9 * the whole document *

DOI:   http://dx.doi.org/10.1002/pd.4811
by applicant   - DASANAYAKE AP; BOYD D; MADIANOS PN; OFFENBACHER S; HILLS E, J Periodontol, (20011100), vol. 72, no. 11, pages 1491 - 7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.